cetyl palmitate has been researched along with glyceryl behenate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hahn, H; Katzfey, U; Liesenfeld, O; Müller, RH; Schöler, N; Zimmermann, E | 1 |
| Blasi, P; Bonina, F; Giovagnoli, S; Puglia, C; Ricci, M; Rossi, C; Schoubben, A | 1 |
| Doktorovova, S; Silva, AM; Souto, EB; Zielinska, A | 1 |
3 other study(ies) available for cetyl palmitate and glyceryl behenate
| Article | Year |
|---|---|
Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages.
Topics: Animals; Cell Survival; Culture Media, Conditioned; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Enzyme-Linked Immunosorbent Assay; Excipients; Fatty Acids; Female; Interleukin-12; Interleukin-6; Lipids; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Palmitates; Particle Size; Poloxamer; Preservatives, Pharmaceutical; Thimerosal; Tumor Necrosis Factor-alpha | 2000 |
Lipid nanoparticles for brain targeting I. Formulation optimization.
Topics: Brain; Computer-Aided Design; Drug Carriers; Drug Delivery Systems; Fatty Acids; Infusions, Intravenous; Lipids; Nanoparticles; Palmitates; Particle Size; Temperature; Triglycerides | 2011 |
Key production parameters for the development of solid lipid nanoparticles by high shear homogenization.
Topics: Diglycerides; Drug Carriers; Drug Compounding; Fatty Acids; Lipids; Nanoparticles; Palmitates; Particle Size; Poloxamer; Stearic Acids; Surface-Active Agents | 2019 |